UN One Health push could spawn a second-order market for biological interoperability software
The UN chief's call for a global, equity-based One Health approach signals the emergence of a new, second-order market for cross-domain data platforms.
Edward Mullen ·
When a zoonotic spillover event unfolds, a vet in a rural clinic might register unusual symptoms in livestock, while a human health worker notes a spike in localized fever cases. Their disparate observations, often recorded in separate systems, represent critical early warning signals. The UN’s call for a ‘One Health’ approach posits that connecting these dots is no longer optional, but essential. This regulatory push will forge a specialized market for interoperable biological data platforms.
One Health and the interoperability imperative
The UN’s framing treats pandemic readiness as an architectural challenge: how to connect disparate data streams from human clinics, veterinary surveillance, and environmental monitors into a common operating picture. That requires technical standards, governance mechanisms, and trust across ministries that historically operated in separate silos.
It also implies a shift in who builds and maintains the infrastructure—the kind of cross-domain software and data platforms that can ingest, harmonize, and securely share records at border crossings, ports of entry, and rural clinics alike. This is not simply about dashboards; it is about end-to-end workflows, from sampling and sequencing to risk assessment and community notifications, all synchronized across jurisdictions.
The speech’s emphasis on equity and solidarity underlines a governance problem as much as a technical one: who pays, who controls, and who benefits from shared data?
Those governance questions hint at a second-order market forming around specialized interoperability software and data platforms. In practice, regulators, health ministries, and international bodies would need to converge on common data schemas, privacy rules, consent mechanisms, and access controls that survive cross-border exchange.
Rather than a single health IT system, executives should anticipate a family of interoperable layers—standards bodies, data-translation services, crosswalks between animal health records and human health records, and secure data lakes that can scale with surveillance intensity. The outcome would be a market where software vendors and consortia compete on the ease of integration, security, and the ability to maintain continuity of operations during surges.
The One Health data problem, not just a policy problem The central hurdle is data interoperability at scale. Agencies will need to harmonize disparate data types: clinical case reports, veterinary diagnoses, wildlife surveillance, environmental sensors, and even climate indicators. Each data type carries distinct privacy, regulatory, and ethics constraints, making standardization a nontrivial undertaking. A successful approach will require interoperable data models that preserve context, lineage, and provenance, plus mechanisms for access governance that satisfy diverse national laws and international norms. The One Health framing is a call to design software architectures that can be audited, certified, and updated in concert with evolving scientific knowledge. It is a technical program as much as a diplomatic one, and the regulatory dimension will be decisive in shaping who can participate and under what conditions.
The UN’s emphasis on community engagement and local health workers also matters for the design of these platforms. Interoperable systems must work in settings with uneven digital infrastructure, limited bandwidth, and variable levels of technical capacity.
In turn, vendors will need to offer adaptable deployment models—on-premises, cloud-based, or hybrid—that align with national sovereignty concerns and public finance constraints. These considerations push the market toward modular, scalable solutions rather than monolithic tools, with procurement strategies that favor shared standards and open interoperability over bespoke, single-vendor products.
The overarching regulatory agenda—funding commitments, cross-border data governance, and platform accountability—will guide who wins or loses in this emerging market.
Procurement, procurement, and ongoing infrastructure costs
If the One Health approach is to become a durable capability, governments will likely treat interoperability platforms as ongoing systems rather than one-off purchases. That implies a shift in cost structure: from upfront capex for hardware and one-time software licenses to ongoing opex for cloud services, data harmonization, and platform maintenance.
The financial dimension intersects with governance: predictable, multi-year funding must align with the lifecycle of data standards, stewardship, and updates to regulatory requirements. In practice, this could reframe procurements around multi-stakeholder consortia and shared platforms, where national health ministries, ministries of agriculture, and environmental agencies jointly fund and govern the core interoperability layer.
The result could be greater resilience but also more complex contracting, performance metrics, and accountability rails than traditional health IT procurements.
Beyond public sector budgeting, the private sector could contribute through public–private partnerships that finance shared data infrastructure, with clear returns in faster outbreak detection, better outbreak response coordination, and more efficient allocation of scarce resources. Yet the economics will hinge on shared standards and durable governance—without them, the interoperability market risks fragmentation, vendor lock-in, or misaligned incentives that undercut public health goals.
A regulated, standards-driven market is more likely to produce durable capabilities than a patchwork of bespoke systems built to satisfy individual agencies. The UN’s call binds these questions to a broader international framework, making the regulatory environment as critical as the software itself.
Signals to watch over the next 12–18 months
The most salient test is whether the market actually materializes around cross-species data interoperability. If within the next year a major software vendor or a government-led consortium announces a One Health–specific interoperability platform, it would be a strong sign that the architecture gap is becoming a regulated market.
Conversely, if no platform emerges and the WHO’s pandemic agreement advances without explicit data-sharing standards for cross-species platforms, that would suggest the regulatory and standards gaps are still insurmountable barriers. A third signal would be shifts in funding patterns: venture dollars flowing into startups focused on cross-domain data integration, privacy-preserving data exchange, and governance tooling would indicate that the market is moving from concept to commercial practice.
If funding remains flat, the second-order market thesis weakens. These three signals provide a concrete, falsifiable test of whether the One Health data interoperability vision evolves into a regulated, vendor-driven market or remains a policy aspiration.
The regulatory frame will also be revealing.
If the WHO pandemic framework begins to articulate explicit requirements for cross-species data platforms—data formats, exchange protocols, provenance, and access controls—it would reinforce the case for a durable, standards-based market. If not, the regulatory path could stay aspirational, allowing pilot projects but limiting scale.
Either trajectory will shape procurement strategies and vendor positioning for the next 18 months, with implications not just for health IT but for any sector seeking multi-stakeholder, globally interoperable data architectures.
In sum, the UN’s call does more than echo a policy preference; it reframes pandemics as an architectural problem that pressure-tests a new class of software and data platforms. Executives should watch whether the regulatory and market signals align to create a second-order market for biological interoperability, or whether the patchwork of existing systems merely stiffens under strain.
The outcome will influence how public health preparedness evolves—toward shared data ecosystems—or remains a collection of jurisdiction-specific tools that struggle to scale when a new threat emerges.